Galendi, Julia Simoes Correa, Yeo, Sin Yuin ORCID: 0000-0002-7602-0695, Simic, Dusan, Gruell, Holger, Stock, Stephanie and Mueller, Dirk (2022). A time-driven activity-based costing approach of magnetic resonance-guided high-intensity focused ultrasound for cancer-induced bone pain. Int. J. Hyperthermia, 39 (1). S. 173 - 181. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1464-5157

Full text not available from this repository.

Abstract

Objective To determine resource consumption and total costs for providing magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) treatment to a patient with cancer-induced bone pain (CIBP). Methods We conducted a time-driven activity-based costing (TD-ABC) of MR-HIFU treatments for CIBP from a hospital perspective. A European care-pathway (including a macro-, meso-, and micro-level) was designed to incorporate the care-delivery value chain. Time estimates were obtained from medical records and from prospective direct observations. To calculate the capacity cost rate, data from the controlling department of a German university hospital were allocated to the modules of the care pathway. Best- and worst-case scenarios were calculated by applying lower and upper bounds of time measurements. Results The macro-level care pathway consisted of eight modules (i.e., outpatient consultations, pretreatment imaging, preparation, optimization, sonication, post-treatment, recovery, and anesthesia). The total cost of an MR-HIFU treatment amounted to euro5147 per patient. Best- and worst-case scenarios yielded a total cost of euro4092 and to euro5876. According to cost categories, costs due to equipment accounted for 41% of total costs, followed by costs with personnel (32%), overhead (16%) and materials (11%). Conclusion MR-HIFU is an emerging noninvasive treatment for alleviating CIBP, with increasing evidence on treatment efficacy. This costing study can support MR-HIFU reimbursement negotiations and facilitate the adoption of MR-HIFU as first-line treatment for CIBP. The present TD-ABC model creates the opportunity of benchmarking the provision of MR-HIFU to bone tumor.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Galendi, Julia Simoes CorreaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yeo, Sin YuinUNSPECIFIEDorcid.org/0000-0002-7602-0695UNSPECIFIED
Simic, DusanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gruell, HolgerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stock, StephanieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mueller, DirkUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-663556
DOI: 10.1080/02656736.2021.2023768
Journal or Publication Title: Int. J. Hyperthermia
Volume: 39
Number: 1
Page Range: S. 173 - 181
Date: 2022
Publisher: TAYLOR & FRANCIS LTD
Place of Publication: ABINGDON
ISSN: 1464-5157
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
HEALTH-CARE; UTERINE FIBROIDS; METASTASES; RADIOTHERAPY; ANESTHESIA; PALLIATION; RADIATION; ABLATION; SINGLEMultiple languages
Oncology; Radiology, Nuclear Medicine & Medical ImagingMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/66355

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item